Inorganic-polymer nanohybrid carrier for delivery of a poorly-soluble drug, ursodeoxycholic acid

International Journal of Pharmaceutics

Volumn 402, Issue 1-2, 2010, Pages 117-122

  Choi, Goeun ^a   Lee, Ji Hee ^a   Oh, Yeon Ji ^a   Choy, Young Bin ^b   Park, Myung Chul ^a   Chang, Hee Chul ^c   Choy, Jin Ho ^a  

^a Ewha Womans University   (South Korea)

^b Seoul National University   (South Korea)

^c Daewoong Pharmaceutical Co Ltd   (South Korea)

Author keywords

Drug delivery; Layered double hydroxide; Nanovehicle; Polymer coating; Poorly soluble drugs; Solubility enhancement

Indexed keywords

EUDRAGIT; EUDRAGIT S100; NANOCARRIER; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ARTICLE; BODY FLUID; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; SIMULATION; X RAY POWDER DIFFRACTION;

CHOLAGOGUES AND CHOLERETICS; DRUG CARRIERS; DRUG STABILITY; EXCIPIENTS; HYDROXIDES; POLYMETHACRYLIC ACIDS; POWDER DIFFRACTION; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STATIC ELECTRICITY; TIME FACTORS; URSODEOXYCHOLIC ACID; X-RAY DIFFRACTION;

EID: 78349312940     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.09.039     Document Type: Article

References (46)

1. Aguzzi C., Cerezo P., Viseras C., Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 2007, 36:22-36.
2. Aisawa S., Takahashi S., Oggasawara W., Umetsu Y., Narita E. Direct intercalation of amino acids into layered double hydroxides by coprecipitation. J. Solid State Chem. 2001, 162:52-62.
3. ® on the properties of lipid controlled release microparticles. J. Control. Rel. 2004, 100:233-246.
4. Ambrogi V., Fardella G., Grandolini G., Perioli L. Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents - I. Intercalation and in vitro release of ibuprofen. Int. J. Pharm. 2001, 220:23-32.
5. Ambrogi V., Fardella G., Grandolini G., Nocchetti M., Perioli L. Effect of hydrotalcite-like compounds on the aqueous solubility of some poorly water-soluble drugs. J. Pharm. Sci. 2003, 92:1407-1418.
6. Choi W.S., Kim H.I., Kwak S.S., Chung H.Y., Chung H.Y., Yamamoto K., Oguchi T., Tozuka Y., Yonemochi E., Terada K. Amorphous ultrafine particle preparation for improvement of bioavailability of insoluble drugs: grinding characteristics of fine grinding mills. Int. J. Miner. Process. 2004, 74S:S165-S172.
7. Choi S.J., Oh J.M., Choy J.H. Human-related application and nanotoxicology of inorganic particles: complementary aspects. J. Mater. Chem. 2008, 18:615-620.
8. Choy J.H., Kwak S.Y., Park J.S., Jeong Y.J., Portier J. Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide. J. Am. Chem. Soc. 1999, 121:1399-1400.
9. Choy J.H., Jung J.S., Oh J.M., Park M., Jeong J.Y., Kang Y.K., Han O.J. Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials 2004, 25:3059-3064.
10. Choy J.H., Choi S.J., Oh J.M., Park T. Clay minerals and layered double hydroxides for novel biological applications. Appl. Clay Sci. 2007, 36:122-132.
11. Chung H.Y., Yonemochi E., Saitoh T., Terada K., Tozuka Y., Oguchi T., Yamamoto K., Chung H.Y., Choi W.S. Factors affecting the apparent solubility of ursodeoxycholic acid in the grinding process. Int. J. Pharm. 2003, 255:49-56.
12. Denga Z., Xu S., Li S. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications. Int. J. Pharm. 2008, 351:236-243.
13. Fini A., Fazio G., Feroci G. Solubility and solubilization properties of non-steroidal anti-inflammatory drugs. Int. J. Pharm. 1995, 126:95-102.
14. Fleisher D., Bong R., Stewart B.H. Improved oral drug delivery: solubility limitations overcome by the use of prodrugs. Adv. Drug Deliv. Rev. 1996, 19:115-130.
15. Hu J., Johnston K.P., Williams R.O. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev. Ind. Pharm. 2004, 30:233-245.
16. Jiao F.P., Chen X.Q., Fu Z.D., Hu Y.H., Wang Y.H. Intercalation of Mg-Al layered double hydroxides by (+)-dibenzoyl-d-tartaric acid: preparation and characterization. J. Mol. Struct. 2009, 921:328-332.
17. Jung H., Kim H.M., Choy Y.B., Hwang S.J., Choy J.H. Itraconazole-Laponite: kinetics and mechanism of drug release. Appl. Clay Sci. 2008, 40:99-107.
18. Jung H., Kim H.M., Choy Y.B., Hwang S.J., Choy J.H. Laponite-based nanohybrid for enhanced solubility and controlled release of itraconazole. Int. J. Pharm. 2008, 349:283-290.
19. Khan A.I., Lei L., Norquist A.J., O'Hare D. Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide. Chem. Commun. 2001, 2342-2343.
20. Kipp J.E. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm. 2004, 284:109-122.
21. Kloprogge J.T., Frost R.L. Fourier Transform infrared and raman spectroscopic study of the local structure of Mg-, Ni-, and co-hydrotalcites. J. Solid State Chem. 1999, 146:506-515.
22. Kondo M., Niwa T., Okamoto H., Danjo K. Particle characterization of poorly water-soluble drugs using a spray freeze drying technique. Chem. Pharm. Bull. 2009, 57(7):657-662.
23. Kuu W.Y., Chilamkurti R., Chen C. Effect of relative humidity and temperature on moisture sorption and stability of sodium bicarbonate powder. Int. J. Pharm. 1998, 166:167-175.
24. Kwak S.Y., Kriven W.M., Wallig M.A., Choy J.H. Inorganic delivery vector for intravenous injection. Biomaterials 2004, 25:5995-6001.
25. Li B., He J., Evans D.G., Duan X. Enteric-coated layered double hydroxides as a controlled release drug delivery system. Int. J. Pharm. 2004, 287:89-95.
26. Li B., He J., Evans D.G., Duan X. Inorganic layered double hydroxides as a drug delivery system-intercalation and in vitro release of fenbufen. Appl. Clay Sci. 2004, 27:199-207.
27. Lin F.H., Lee Y.H., Jian C.H., Wong J.M., Shieh M.J., Wang C.Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 2002, 23:1981-1987.
28. Methaacrylate Polymers for Pharmaceutical Applications, 2005. Degussa AG, Pharma Polymers, Kirschenallee, 64293 Darmstadt, Germany, pp. Info 7.3/E.
29. Oguchi T., Sasaki N., Hara T., Tozuka Y., Yamamoto K. Differentiated thermal crystallization from amorphous chenodeoxycholic acid between the ground specimens derived from the polymorphs. Int. J. Pharm. 2003, 253:81-88.
30. Orienti I., Cerchiara T., Zecchi V., Arias Blanco M.J., Gines J.M., Moyano J.R., Rabasco Alvarez A.M. Complexation of ursodeoxycholic acid with β-cyclodextrin-choline dichloride coprecipitate. Int. J. Pharm. 1999, 190:139-153.
31. Park J.K., Choy Y.B., Oh J.M., Kim J.Y., Hwang S.J., Choy J.H. Controlled release of donepezil intercalated in smectite clays. Int. J. Pharm. 2008, 359:198-204.
32. Pavia D.L., Lampman G.M., Kriz G.S. Introduction to Spectroscopy 1996, Harcourt Brace College.
33. Porter C.J.H., Pouton C.W., Cuine J.F., Charman W.N. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev. 2008, 60:673-691.
34. Prasanna S.V., Kamath P.V. Synthesis and characterization of arsenate-intercalated layered double hydroxides (LDHs): prospects for arsenic mineralization. J. Colloid Interface Sci. 2009, 331:439-445.
35. Remenar J.F., Morissette S.L., Peterson M.L., Moulton B., MacPhee J.M., Guzmaón H.R., Almarsson O. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J. Am. Chem. Soc. 2003, 125:8456-8457.
36. Shah J.C., Chen J.R., Chow D. Preformulation study of etoposide: II. Increased solubility and dissolution rate by solid-solid dispersions. Int. J. Pharm. 1995, 113:103-111.
37. Shakeel F., Faisal M.S. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib. Pharm. Dev. Technol. 2009, (1-4, iFirst).
38. Sugimoto M., Okagaki T., Narisawa S., Koida Y., Nakajima K. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer. Int. J. Pharm. 1998, 160:11-19.
39. The United States Pharmacopoeia, 25th ed., 2002a. United States Pharmacopeial Convention, Rockville, MD, pp. 2011-2012.
40. The United States Pharmacopoeia, 25th ed., 2002b. United States Pharmacopeial Convention, Rockville, MD, p. 1788.
41. Ventura C.A., Tirendi S., Puglisi G., Bousquet E., Panza L. Improvement of water solubility and dissolution rate of ursodeoxycholic acid and chenodeoxycholic acid by complexation with natural and modified β-cyclodextrins. Int. J. Pharm. 1997, 149:1-13.
42. Vogt M., Kunath K., Dressman J.B. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients. Eur. J. Pharm. Biopharm. 2008, 68:330-337.
43. Waterman K.C., Adami R.C. Accelerated aging: prediction of chemical stability of pharmaceuticals. Int. J. Pharm. 2005, 293:101-125.
44. Yang J.H., Han Y.S., Park M., Park T., Hwang S.J., Choy J.H. New inorganic-based drug delivery system of indole-3-acetic acid-layered metal hydroxide nanohybrids with controlled release rate. Chem. Mater. 2007, 19:2679-2685.
45. Yasuji T., Takeuchi H., Kawashima Y. Particle design of poorly water-soluble drug substances using supercritical fluid technologies. Adv. Drug Deliv. Rev. 2008, 60:388-398.
46. Zhao H., Nagy K.L. Dodecyl sulfate-hydrotalcite nanocomposites for trapping chlorinated organic pollutants in water. J. Colloid Interface Sci. 2004, 274:613-624.